These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 5255682

  • 1. [Chronic myeloid leukemia with a long survival time].
    de Vries SI.
    Ned Tijdschr Geneeskd; 1969 Jul 12; 113(28):1225-6. PubMed ID: 5255682
    [No Abstract] [Full Text] [Related]

  • 2. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].
    Larrain C, Cruz A, Codoceo V.
    Rev Med Chil; 1984 Sep 12; 112(9):898-911. PubMed ID: 6598227
    [No Abstract] [Full Text] [Related]

  • 3. The long-term results and survival in the treatment of chronic granulocytic leukaemia with Myleran.
    Chrobák L, Radochová D, Chrobáková H.
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1969 Sep 12; 12(5):565-70. PubMed ID: 5267593
    [No Abstract] [Full Text] [Related]

  • 4. [Course and prognosis of chronic myeloid leukemia treated with busulfan. Study of 300 cases].
    Ionescu V.
    Dtsch Med Wochenschr; 1971 May 14; 96(20):867-70. PubMed ID: 5280862
    [No Abstract] [Full Text] [Related]

  • 5. [Remarks on the course and prognostic factors in a series of chronic myeloid leukemia].
    Furno F, Neretto G, Mazza A, Giovanelli E, Agricola R, Martinetto P.
    Arch Sci Med (Torino); 1980 May 14; 137(3):499-506. PubMed ID: 6940518
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of chronic myeloid leukemia with repeated single doses of busulfan.
    Sullivan JR, Hurley TH, Bolton JH.
    Cancer Treat Rep; 1977 May 14; 61(1):43-5. PubMed ID: 266418
    [Abstract] [Full Text] [Related]

  • 7. Prolonged remission in chronic myeloid leukemia after a single course of myleran.
    Djaldetti M, Pinkhas J, Padeh B, De Vries A.
    Isr J Med Sci; 1965 Jul 14; 1(4):827-8. PubMed ID: 5216389
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of 100 cases of chronic myeloid leukemia with Myleran.
    Pawelski S, Topolska P, Rechowicz K, Krzyzanowska-Wozniakowska.
    Pol Med Sci Hist Bull; 1968 Jul 14; 11(3):101-4. PubMed ID: 5243952
    [No Abstract] [Full Text] [Related]

  • 9. [Modification of the prognosis of chronic myeloid leukemia through current treatment].
    Donner L, Klener P, Roth Z.
    Vnitr Lek; 1976 Feb 14; 22(2):114-9. PubMed ID: 1062868
    [No Abstract] [Full Text] [Related]

  • 10. [Survival of 29 cases of chronic myeloid leukemia treated by myleran].
    Petitclerc C, Barry A.
    Union Med Can; 1976 Feb 14; 105(2):210-6. PubMed ID: 1069396
    [No Abstract] [Full Text] [Related]

  • 11. Survival in chronic granulocytic leukemia. Splenic irradiation vs busulfan.
    Conrad FG.
    Arch Intern Med; 1973 May 14; 131(5):684-5. PubMed ID: 4512787
    [No Abstract] [Full Text] [Related]

  • 12. [Chronic granulocytic leukaemia (CGL): results of continuous busulphan mono-chemotherapy in 160 cases (1960-1980) (author's transl)].
    Sánchez Fayos J, Outeiriño J, de Villalobos E, Valera M, Alonso M, Calabuig MT, Paniagua G.
    Sangre (Barc); 1981 May 14; 26(1):65-71. PubMed ID: 6942520
    [No Abstract] [Full Text] [Related]

  • 13. [Results of treatment and survival time in chronic granulocytic leukemia].
    Pawlowski J.
    Przegl Lek; 1969 May 14; 25(3):305-9. PubMed ID: 4182966
    [No Abstract] [Full Text] [Related]

  • 14. [Long-term survival in chronic granulocytic leukemia].
    Coliţă A, Butoianu E, Nicoară S, Gociu M, Munteanu N, Hossu T, Ciocoiu A, Berceanu S.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983 May 14; 35(3):247-52. PubMed ID: 6140719
    [No Abstract] [Full Text] [Related]

  • 15. [Observations on the terminal course of chronic myeloid leukemia treated by alkylating agents (busulfan)].
    Giovanelli E.
    Minerva Med; 1970 May 19; 61(37):2038-41. PubMed ID: 4097050
    [No Abstract] [Full Text] [Related]

  • 16. [Prognostic factors in chronic myeloid leukemia. Apropos of 798 cases].
    Jacquillat C, Chastang C, Bancalari G, Weil M, Bernard J.
    Ann Med Interne (Paris); 1975 May 19; 126(6-7):515-20. PubMed ID: 1065252
    [No Abstract] [Full Text] [Related]

  • 17. [Analysis of clinical and laboratory prognostic indices in chronic myeloid leukemia (author's transl)].
    Kotlarek-Haus S, Becker M, Dorczak K.
    Przegl Lek; 1977 May 19; 34(4):407-11. PubMed ID: 267958
    [No Abstract] [Full Text] [Related]

  • 18. [Recent concepts of chronic myeloid leukemia and its treatment].
    Bousser J, Bilski-Pasquier G, Zittoun.
    Bull Mem Soc Med Hop Paris; 1977 May 19; 117(8):665-74. PubMed ID: 5224894
    [No Abstract] [Full Text] [Related]

  • 19. [Very long survivals of chronic granulocytic leukemia (author's transl)].
    Debray J, Pommier Y, Audebert AA, Krulik M, Smadja N, Zylberait D.
    Sem Hop; 1977 May 19; 56(7-8):309-13. PubMed ID: 6246623
    [Abstract] [Full Text] [Related]

  • 20. [Therapy of the blastic crisis].
    Tura S, Baccarani M, Bagnara GP.
    Minerva Med; 1972 Mar 31; 63(24):1459-67. PubMed ID: 4502509
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.